HC Wainwright maintains $120 price target for Oruka Therapeutics
HC Wainwright & Co. maintained its $120.00/share price target on Oruka Therapeutics,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.